KamangarFMalekzadehRDawseySMSaidiF.Esophageal cancer in Northeastern Iran: a review. Arch Iran Med. 2007;10(1):70-82.
3.
African Esophageal Cancer Consortium. Expanding oesophageal cancer research and care in eastern Africa.Nat Rev Cancer. 2022;22(5):253-254. doi:10.1038/s41568-022-00458-1
4.
TuynsAJ.Oesophageal cancer in non-smoking drinkers and in non-drinking smokers. Int J Cancer. 1983;32:443-444.
5.
MangalaparthiKKPatelKKhanAA, et al. Mutational landscape of esophageal squamous cell carcinoma in an Indian cohort. Front Oncol. 2020;10:1457. doi:10.3389/fonc.2020.01457
6.
BoffettaPGarfinkelL.Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology. 1990;1:342-348.
7.
LeeCHLeeJMWuDC, et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer. 2005;113(3):475-482.
WangLDZhengSZhengZYCassonAG.Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol. 2003;9(6):1156-1164. doi:10.3748/wjg.v9.i6.1156
10.
LiJYErshowAGChenZJ, et al. A case-control study of cancer of the esophagus and gastric cardia in Linzhou. Int J Cancer. 1989;43:755-761.
11.
ThenEOLopezMSaleemS, et al. Esophageal cancer: an updated surveillance epidemiology and end results database analysis. World J Oncol. 2020;11(2):55-64. doi:10.14740/wjon1254
SreedharanAHarrisKCrellinAFormanDEverettSM.Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2009;4:CD005048.
14.
DaiYLiCXieY, et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2014;10:CD005048.
15.
NagarajaVCoxMREslickGD.Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. J Gastrointest Oncol. 2014;5(2):119-126. doi:10.3978/j.issn.2078-6891.2014.007
16.
DeressaBTTigenehWBogaleNBuwengeMMorgantiAGFarinaE.Short-course 2-dimensional radiation therapy in the palliative treatment of esophageal cancer in a developing country: a phase II study (Sharon Project). Int J Radiat Oncol Biol Phys. 2020;106(1):67-72. doi:10.1016/j.ijrobp.2019.10.004
17.
FerndaleLSartoriusBAldousCThomsonSR.Oesophageal cancer in Area 2 of Kwazulu-Natal: predictors of late presentation. S Afr J Surg. 2019;57(2):4-9.
18.
BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalA.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi:10.3322/caac.21492
19.
Van LoonKMwachiroMMAbnetCC, et al. The African esophageal cancer consortium: a call to action. J Glob Oncol. 2018;4:1-9. doi:10.1200/JGO.17.00163
20.
WenTWangWChenX.Recent advances in esophageal squamous cell precancerous conditions: a review. Medicine (Baltimore). 2022;101(50):e32192. doi:10.1097/MD.0000000000032192
21.
SimbaHTrompGSewramVMathewCGChenWCKuivaniemiH.Esophageal cancer genomics in Africa: recommendations for future research. Front Genet. 2022;13:864575. doi:10.3389/fgene.2022.864575
22.
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature. 2020;578:82-93. doi:10.1038/s41586-020-1969-6
23.
AjaniJ.Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers. Cancer. 2006;107(2):221-231. doi:10.1002/cncr.21986
FoliakiSBatesCTukanaIPalafoxNA.Cancer control in the Pacific: a South Pacific collaborative approach. Cancer Epidemiol. 2017;50(Pt B):193-198. doi:10.1016/j.canep.2017.06.001
